Pair Name	Gamma-Tocotrienol, Gemcitabine
Disease Info	[ICD-11: 2C10.Z]	Pancreatic cancer		Investigative
Biological Phenomena	Induction-->Apoptosis
Gene Regulation	Down-regulation	Expression	NFKB1	hsa4790
	Down-regulation	Expression	CCND1	hsa595
	Down-regulation	Expression	MYC	hsa4609
	Down-regulation	Expression	COX2	hsa4513
	Down-regulation	Expression	BCL2	hsa596
	Down-regulation	Expression	BIRC2	hsa329
	Down-regulation	Expression	BCL-xL	hsa598
	Down-regulation	Expression	VEGFA	hsa7422
	Down-regulation	Expression	MMP9	hsa4318
	Down-regulation	Expression	CXCR4	hsa7852
	Up-regulation	Activity	CASP3	hsa836
	Up-regulation	Activity	CASP9	hsa842
In Vitro Model	MIA PaCa-2	Pancreatic ductal adenocarcinoma	Homo sapiens (Human)	CVCL_0428
In Vivo Model	MIA PaCa-2 cells (1×10⁶) in 100 µL PBS were injected into the subcapsular region of the pancreas with a 27-gauge needle and a calibrated push button-controlled dispensing device.
Result	Our findings suggest that γ-T3 can inhibit the growth of human pancreatic tumors and sensitize them to gemcitabine by suppressing NF-κB-mediated inflammatory pathways linked to tumorigenesis.